Similar articles

• Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.

  Stroncek DF, Clay ME, Smith J, Ilstrup S, Oldham F, McCullough J. Stroncek DF, et al. Transfusion. 1996 Jul;36(7):596-600. doi: 10.1046/j.1537-2995.1996.36796323058.x. Transfusion. 1996. PMID: 8701454
• Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donors.

  Fürst D, Hauber D, Reinhardt P, Schauwecker P, Bunjes D, Schulz A, Mytilineos J, Wiesneth M, Schrezenmeier H, Körper S. Fürst D, et al. Vox Sang. 2019 Apr;114(3):275-282. doi: 10.1111/vox.12754. Epub 2019 Mar 14. Vox Sang. 2019. PMID: 30873634
• Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.

  Nademanee AP, DiPersio JF, Maziarz RT, Stadtmauer EA, Micallef IN, Stiff PJ, Hsu FJ, Bridger G, Bolwell BJ. Nademanee AP, et al. Biol Blood Marrow Transplant. 2012 Oct;18(10):1564-72. doi: 10.1016/j.bbmt.2012.05.017. Epub 2012 Jun 6. Biol Blood Marrow Transplant. 2012. PMID: 22683613 Clinical Trial.
• [Features of chronic myeloid leukemia at diagnosis. Study of a series of 134 cases].

  Jonte F, Barez A, Soto I, Rayón C, Carrera D, Coma A, Pérez Llanderal J, Arribas M. Jonte F, et al. Sangre (Barc). 1992 Oct;37(5):345-50. Sangre (Barc). 1992. PMID: 1293773 Review. Spanish.
• Clinical utility in maximizing CD34+ cell count in stem cell grafts.

  Burt RK. Burt RK. Stem Cells. 1999;17(6):373-6. doi: 10.1002/stem.170373. Stem Cells. 1999. PMID: 10606166 Review.